300
Participants
Start Date
November 30, 2011
Primary Completion Date
July 31, 2014
Study Completion Date
July 31, 2014
MRC375
MRC 375 (enteric coated Tetracycline) 75mg 3 times a day for 24 weeks.
Matching Placebo
Matching Placebo 3 times a day for 24 weeks. Early escape at week 16,20.
MRC375 150mg
MRC375 (enteric coated Tetracycline) 150mg 3 times a day for 24 weeks
The Center for Excellence in Aging and Geriatric Health, Williamsburg
PMG Research of Salisbury, Salisbury
Riverside Clinical Research, Edgewater
Global Clinical Professionals, Miami
Lakeview Medical Research, Summerfield
The Arthritis Center, Palm Harbor
Mobile Diagnostic Center Rheumatology, Mobile
Trial Concierge, Owensboro
Paramount Medical Research & Consulting, LLC, Middleburg Heights
Providence Health Partners, Dayton
Analan Clinical Research, Lenexa
Quality Clinical Research, Inc., Omaha
Advanced BioMedical Research of America, Las Vegas
Arthritis Center of Reno, Reno
Axis Clinical Trials, Los Angeles
Trial Concierge/Pacific Clinical Studies, Los Alamitos
Valerius Medical Group, Long Beach
South Puget Sound Clinical Research Center, Olympia
Apex Clinical Research, Kennewick
Camargo Pharmaceutical Services
INDUSTRY
Clin Data Services
UNKNOWN
Harrison Clinical Research
INDUSTRY
BARC Global Central Laboratory
UNKNOWN
Bilcare Global Clinical Supplies
UNKNOWN
Molecular Research Center, Inc.
INDUSTRY